Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-021777
Filing Date
2025-02-06
Accepted
2025-02-06 16:06:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d875218ddefa14a.htm DEFA14A 37340
  Complete submission text file 0001193125-25-021777.txt   38543
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39244 | Film No.: 25597366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)